Mallinckrodt Pharmaceuticals Announces Executive Appointments
Published: Oct 24, 2013
Mallinckrodt plc (NYSE: MNK), a global specialty pharmaceuticals company, today announced three appointments to the Company’s senior management team. This will round out Mallinckrodt’s executive leadership and help drive the Company’s strategic focus toward growing its core business as a specialty pharmaceutical company. The newly appointed executives, all of whom are new to the Company, have served at some of the most prestigious companies in the health care and pharmaceutical field, and together they have a collective 70-plus years of experience in the industry.
Help employers find you! Check out all the jobs and post your resume.